Segui
Angelo Andriulli
Angelo Andriulli
Casa Sollievo Sofferenza
Email verificata su operapadrepio.it
Titolo
Citata da
Citata da
Anno
Incidence rates of post-ERCP complications: a systematic survey of prospective studies
A Andriulli, S Loperfido, G Napolitano, G Niro, MR Valvano, F Spirito, ...
Official journal of the American College of Gastroenterology| ACG 102 (8…, 2007
12572007
Pneumatic dilation versus laparoscopic Heller's myotomy for idiopathic achalasia
GE Boeckxstaens, V Annese, SB Varannes, S Chaussade, M Costantini, ...
New England Journal of Medicine 364 (19), 1807-1816, 2011
8972011
Peginterferon alfa-2b and ribavirin for 12 vs. 24 weeks in HCV genotype 2 or 3
A Mangia, R Santoro, N Minerva, GL Ricci, V Carretta, M Persico, F Vinelli, ...
New England Journal of Medicine 352 (25), 2609-2617, 2005
8372005
Genome-wide association identifies multiple ulcerative colitis susceptibility loci
DPB McGovern, A Gardet, L Trkvist, P Goyette, J Essers, KD Taylor, ...
Nature genetics 42 (4), 332-337, 2010
7172010
Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) guideline–updated June 2014
JM Dumonceau, A Andriulli, BJ Elmunzer, A Mariani, T Meister, J Deviere, ...
Endoscopy 46 (09), 799-815, 2014
6432014
European Society of Gastrointestinal Endoscopy (ESGE) Guideline: prophylaxis of post-ERCP pancreatitis
JM Dumonceau, A Andriulli, J Devire, A Mariani, J Rigaux, TH Baron, ...
Endoscopy 42 (06), 503-515, 2010
4532010
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis
X Liu, P Invernizzi, Y Lu, R Kosoy, Y Lu, I Bianchi, M Podda, C Xu, G Xie, ...
Nature genetics 42 (8), 658-660, 2010
4362010
A multicentre randomised study of intrasphincteric botulinum toxin in patients with oesophageal achalasia
V Annese, G Bassotti, G Coccia, M Dinelli, V D'Onofrio, G Gatto, ...
Gut 46 (5), 597-600, 2000
3292000
Individualized treatment duration for hepatitis C genotype 1 patients: a randomized controlled trial
A Mangia, N Minerva, D Bacca, R Cozzolongo, GL Ricci, V Carretta, ...
Hepatology 47 (1), 43-50, 2008
3222008
Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia
NH Afdhal, EG Giannini, G Tayyab, A Mohsin, JW Lee, A Andriulli, ...
New England Journal of Medicine 367 (8), 716-724, 2012
3182012
Randomized controlled trial of botulinum toxin versus laparoscopic Heller myotomy for esophageal achalasia
G Zaninotto, V Annese, M Costantini, A Del Genio, M Costantino, ...
Annals of surgery 239 (3), 364, 2004
3152004
Pharmacologic treatment can prevent pancreatic injury after ERCP: a meta-analysis
A Andriulli, G Leandro, G Niro, A Mangia, V Festa, G Gambassi, ...
Gastrointestinal endoscopy 51 (1), 1-7, 2000
3102000
Radiofrequency thermal ablation vs. percutaneous ethanol injection for small hepatocellular carcinoma in cirrhosis: meta-analysis of randomized controlled trials
A Orlando, G Leandro, M Olivo, A Andriulli, M Cottone
Official journal of the American College of Gastroenterology| ACG 104 (2…, 2009
3082009
Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: a multicenter, placebo-controlled, randomized clinical trial
A Andriulli, R Clemente, L Solmi, V Terruzzi, R Suriani, A Sigillito, ...
Gastrointestinal endoscopy 56 (4), 488-495, 2002
2752002
Peginterferon alfa-2b and ribavirin in patients with hepatitis C virus and decompensated cirrhosis: a controlled study
A Iacobellis, M Siciliano, F Perri, BE Annicchiarico, G Leandro, N Caruso, ...
Journal of hepatology 46 (2), 206-212, 2007
2692007
Italian consensus guidelines for chronic pancreatitis
L Frulloni, M Falconi, A Gabbrielli, E Gaia, R Graziani, R Pezzilli, G Uomo, ...
Digestive and Liver Disease 42, S381-S406, 2010
2682010
Pegylated interferon alpha‐2b as monotherapy or in combination with ribavirin in chronic hepatitis delta
GA Niro, A Ciancio, GB Gaeta, A Smedile, A Marrone, A Olivero, ...
Hepatology 44 (3), 713-720, 2006
2672006
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways
HJ Cordell, Y Han, GF Mells, Y Li, GM Hirschfield, CS Greene, G Xie, ...
Nature communications 6 (1), 1-11, 2015
2592015
Controlled trial of botulinum toxin injection versus placebo and pneumatic dilation in achalasia
V Annese, M Basciani, F Perri, G Lombardi, V Frusciante, P Simone, ...
Gastroenterology 111 (6), 1418-1424, 1996
2501996
Randomized study of two “rescue” therapies for Helicobacter pylori-infected patients after failure of standard triple therapies
F Perri, V Festa, R Clemente, MR Villani, M Quitadamo, N Caruso, ...
The American journal of gastroenterology 96 (1), 58-62, 2001
2352001
Il sistema al momento non pu eseguire l'operazione. Riprova pi tardi.
Articoli 1–20